JAMA, ISSN 0098-7484, 05/2013, Volume 309, Issue 18, pp. 1903 - 1911
IMPORTANCE Using more intervals to detect ventricular tachyarrhythmias has been associated with reducing unnecessary implantable cardioverter-defibrillator...
SURVIVAL | MEDICINE, GENERAL & INTERNAL | AMIODARONE | THERAPY | REDUCTION | HEART-FAILURE | TACHYCARDIA | ICD | PRIMARY PREVENTION | Single-Blind Method | Primary Prevention | Arrhythmias, Cardiac - mortality | Arrhythmias, Cardiac - therapy | Defibrillators, Implantable - adverse effects | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Secondary Prevention | Cardiac Pacing, Artificial | Algorithms | Time Factors | Myocardial Ischemia - complications | Quality of Life | Female | Aged | Arrhythmias, Cardiac - diagnosis | Electric Countershock - methods | Surgical outcomes | Defibrillators | Transplants & implants | Cardiology | Heart surgery
SURVIVAL | MEDICINE, GENERAL & INTERNAL | AMIODARONE | THERAPY | REDUCTION | HEART-FAILURE | TACHYCARDIA | ICD | PRIMARY PREVENTION | Single-Blind Method | Primary Prevention | Arrhythmias, Cardiac - mortality | Arrhythmias, Cardiac - therapy | Defibrillators, Implantable - adverse effects | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Secondary Prevention | Cardiac Pacing, Artificial | Algorithms | Time Factors | Myocardial Ischemia - complications | Quality of Life | Female | Aged | Arrhythmias, Cardiac - diagnosis | Electric Countershock - methods | Surgical outcomes | Defibrillators | Transplants & implants | Cardiology | Heart surgery
Journal Article
Circulation, ISSN 0009-7322, 10/2004, Volume 110, Issue 17, pp. 2591 - 2596
Background-Successful antitachycardia pacing (ATP) terminates ventricular tachycardia (VT) up to 250 bpm without the need for painful shocks in implantable...
Pacing | Tachyarrhythmias | Defibrillators | Implantable | CARDIAC & CARDIOVASCULAR SYSTEMS | pacing | BURST | PERIPHERAL VASCULAR DISEASE | QUALITY-OF-LIFE | ALGORITHMS | ICD | TERMINATION | HEMATOLOGY | defibrillators, implantable | tachyarrhythmias | Tachycardia, Ventricular - therapy | Defibrillators, Implantable - adverse effects | Humans | Tachycardia, Ventricular - diagnosis | Quality of Life | Female | Male | Aged | Kinetics | Cardiac Pacing, Artificial - adverse effects
Pacing | Tachyarrhythmias | Defibrillators | Implantable | CARDIAC & CARDIOVASCULAR SYSTEMS | pacing | BURST | PERIPHERAL VASCULAR DISEASE | QUALITY-OF-LIFE | ALGORITHMS | ICD | TERMINATION | HEMATOLOGY | defibrillators, implantable | tachyarrhythmias | Tachycardia, Ventricular - therapy | Defibrillators, Implantable - adverse effects | Humans | Tachycardia, Ventricular - diagnosis | Quality of Life | Female | Male | Aged | Kinetics | Cardiac Pacing, Artificial - adverse effects
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2008, Volume 52, Issue 7, pp. 541 - 550
Objectives Our purpose was to demonstrate that strategically chosen implantable cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular...
MORTALITY | implantable | HEART-FAILURE | ICD | UMCG Approved | cardioversion | CARDIAC RESYNCHRONIZATION | REDUCTION | defibrillation | RX-II TRIAL | RAPID VENTRICULAR-TACHYCARDIA | defibrillators | tachyarrhythmias | CARDIAC & CARDIOVASCULAR SYSTEMS | Tachycardia, Ventricular - therapy | Ventricular Fibrillation - prevention & control | Prospective Studies | Defibrillators, Implantable - adverse effects | Humans | Risk Factors | Male | Tachycardia, Ventricular - prevention & control | Case-Control Studies | Electric Countershock - statistics & numerical data | Incidence | Stroke Volume | Syncope - prevention & control | Tachycardia, Ventricular - physiopathology | Ventricular Fibrillation - physiopathology | Female | Aged | Ventricular Fibrillation - therapy | Heart | Confidence intervals | Cardiac arrhythmia | Heart attacks | Mortality | Morbidity
MORTALITY | implantable | HEART-FAILURE | ICD | UMCG Approved | cardioversion | CARDIAC RESYNCHRONIZATION | REDUCTION | defibrillation | RX-II TRIAL | RAPID VENTRICULAR-TACHYCARDIA | defibrillators | tachyarrhythmias | CARDIAC & CARDIOVASCULAR SYSTEMS | Tachycardia, Ventricular - therapy | Ventricular Fibrillation - prevention & control | Prospective Studies | Defibrillators, Implantable - adverse effects | Humans | Risk Factors | Male | Tachycardia, Ventricular - prevention & control | Case-Control Studies | Electric Countershock - statistics & numerical data | Incidence | Stroke Volume | Syncope - prevention & control | Tachycardia, Ventricular - physiopathology | Ventricular Fibrillation - physiopathology | Female | Aged | Ventricular Fibrillation - therapy | Heart | Confidence intervals | Cardiac arrhythmia | Heart attacks | Mortality | Morbidity
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 12/2011, Volume 34, Issue 12, pp. 1600 - 1606
Background: There are limited options for patients who present with antiarrhythmic‐drug (AAD)‐refractory ventricular tachycardia (VT) with recurrent...
heart failure | sodium current | ICD shocks | ventricular tachycardia | ischemia | Heart failure | Ventricular tachycardia | Ischemia | Sodium current | CARDIAC & CARDIOVASCULAR SYSTEMS | ENGINEERING, BIOMEDICAL | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | SUPPRESSION | Humans | Middle Aged | Mexiletine - therapeutic use | Electric Countershock | Lidocaine - therapeutic use | Male | Sotalol - therapeutic use | Ranolazine | Drug Therapy, Combination - adverse effects | Amiodarone - therapeutic use | Cardiomyopathy, Dilated - drug therapy | Acetanilides - therapeutic use | Electrocardiography | Female | Acetanilides - adverse effects | Hypoglycemia - chemically induced | Defibrillators, Implantable - adverse effects | Tachycardia, Ventricular - drug therapy | Stroke Volume - drug effects | Treatment Outcome | Piperazines - therapeutic use | Anti-Arrhythmia Agents - therapeutic use | Myocardial Ischemia - drug therapy | Piperazines - adverse effects | Anti-Arrhythmia Agents - adverse effects | Myocardial Ischemia - therapy | Aged | Cardiomyopathy, Dilated - therapy | Cohort Studies | Care and treatment | Ablation (Surgery) | Heart beat | Implants, Artificial | Prosthesis | Anti-arrhythmia drugs
heart failure | sodium current | ICD shocks | ventricular tachycardia | ischemia | Heart failure | Ventricular tachycardia | Ischemia | Sodium current | CARDIAC & CARDIOVASCULAR SYSTEMS | ENGINEERING, BIOMEDICAL | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | SUPPRESSION | Humans | Middle Aged | Mexiletine - therapeutic use | Electric Countershock | Lidocaine - therapeutic use | Male | Sotalol - therapeutic use | Ranolazine | Drug Therapy, Combination - adverse effects | Amiodarone - therapeutic use | Cardiomyopathy, Dilated - drug therapy | Acetanilides - therapeutic use | Electrocardiography | Female | Acetanilides - adverse effects | Hypoglycemia - chemically induced | Defibrillators, Implantable - adverse effects | Tachycardia, Ventricular - drug therapy | Stroke Volume - drug effects | Treatment Outcome | Piperazines - therapeutic use | Anti-Arrhythmia Agents - therapeutic use | Myocardial Ischemia - drug therapy | Piperazines - adverse effects | Anti-Arrhythmia Agents - adverse effects | Myocardial Ischemia - therapy | Aged | Cardiomyopathy, Dilated - therapy | Cohort Studies | Care and treatment | Ablation (Surgery) | Heart beat | Implants, Artificial | Prosthesis | Anti-arrhythmia drugs
Journal Article
Circulation: Arrhythmia and Electrophysiology, ISSN 1941-3149, 10/2012, Volume 5, Issue 5, pp. 913 - 919
BACKGROUND—Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD...
Implantable cardioverter-defibrillator shock failure | Defibrillation threshold | Implantable cardioverter-defibrillator | Ventricular tachyarrhythmia | Subcutaneous implantable cardioverter-defibrillator | ventricular tachyarrhythmia | defibrillation threshold | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | implantable cardioverter-defibrillator shock failure | subcutaneous implantable cardioverter-defibrillator | implantable cardioverter-defibrillator | ICD THERAPY | CLINICAL-EXPERIENCE | Tachycardia, Ventricular - therapy | Primary Prevention | Echocardiography | Follow-Up Studies | Humans | Middle Aged | Death, Sudden, Cardiac - prevention & control | Logistic Models | Male | Treatment Outcome | Secondary Prevention | Patient Selection | Stroke Volume | Magnetic Resonance Imaging | Tachycardia, Ventricular - physiopathology | Defibrillators, Implantable | Adult | Female | Aged | Germany
Implantable cardioverter-defibrillator shock failure | Defibrillation threshold | Implantable cardioverter-defibrillator | Ventricular tachyarrhythmia | Subcutaneous implantable cardioverter-defibrillator | ventricular tachyarrhythmia | defibrillation threshold | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | implantable cardioverter-defibrillator shock failure | subcutaneous implantable cardioverter-defibrillator | implantable cardioverter-defibrillator | ICD THERAPY | CLINICAL-EXPERIENCE | Tachycardia, Ventricular - therapy | Primary Prevention | Echocardiography | Follow-Up Studies | Humans | Middle Aged | Death, Sudden, Cardiac - prevention & control | Logistic Models | Male | Treatment Outcome | Secondary Prevention | Patient Selection | Stroke Volume | Magnetic Resonance Imaging | Tachycardia, Ventricular - physiopathology | Defibrillators, Implantable | Adult | Female | Aged | Germany
Journal Article
Heart Rhythm, ISSN 1547-5271, 2013, Volume 10, Issue 5, pp. 702 - 708
Background The efficacy of shock in converting different ventricular tachyarrhythmias has not been well characterized in a large natural-practice setting....
Cardiovascular | Shock | Ventricular tachycardia | ICD | Antitachycardia pacing | Ventricular fibrillation | UNITED-STATES | TRIAL | THRESHOLD | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | SUDDEN CARDIAC DEATH | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | Tachycardia, Ventricular - therapy | United States | Humans | Middle Aged | Electric Countershock | Male | Survival Rate | Treatment Outcome | Tachycardia, Ventricular - physiopathology | Heart Ventricles - physiopathology | Defibrillators, Implantable | Aged, 80 and over | Electrocardiography | Ventricular Fibrillation - physiopathology | Female | Aged | Ventricular Fibrillation - therapy | Health maintenance organizations | Sects | Tachycardia | Implants, Artificial | Prosthesis
Cardiovascular | Shock | Ventricular tachycardia | ICD | Antitachycardia pacing | Ventricular fibrillation | UNITED-STATES | TRIAL | THRESHOLD | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | SUDDEN CARDIAC DEATH | IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | Tachycardia, Ventricular - therapy | United States | Humans | Middle Aged | Electric Countershock | Male | Survival Rate | Treatment Outcome | Tachycardia, Ventricular - physiopathology | Heart Ventricles - physiopathology | Defibrillators, Implantable | Aged, 80 and over | Electrocardiography | Ventricular Fibrillation - physiopathology | Female | Aged | Ventricular Fibrillation - therapy | Health maintenance organizations | Sects | Tachycardia | Implants, Artificial | Prosthesis
Journal Article
Circulation: Arrhythmia and Electrophysiology, ISSN 1941-3149, 09/2017, Volume 10, Issue 9
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 06/2018, Volume 41, Issue 6, pp. 669 - 671
Background The Biotronik DX lead is an attractive option due to its floating atrial bipole and its noninferiority compared to dual‐chamber defibrillators....
ventricular tachycardia | defibrillation‐ICD | defibrillation-ICD | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | ENGINEERING, BIOMEDICAL | HEART-FAILURE | INAPPROPRIATE THERAPY | Tachycardia, Ventricular - therapy | Young Adult | Tachycardia, Ventricular - physiopathology | Algorithms | Defibrillators, Implantable - adverse effects | Humans | Male | Equipment Failure Analysis | Tachycardia | Defibrillators | Ventricle
ventricular tachycardia | defibrillation‐ICD | defibrillation-ICD | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | ENGINEERING, BIOMEDICAL | HEART-FAILURE | INAPPROPRIATE THERAPY | Tachycardia, Ventricular - therapy | Young Adult | Tachycardia, Ventricular - physiopathology | Algorithms | Defibrillators, Implantable - adverse effects | Humans | Male | Equipment Failure Analysis | Tachycardia | Defibrillators | Ventricle
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 05/2013, Volume 36, Issue 5, pp. 635 - 638
implantable cardioverter‐defibrillator (ICD) | ventricular fibrillation (VF) | electric countershock | motor activity | implantable cardioverter-defibrillator (ICD) | CARDIAC & CARDIOVASCULAR SYSTEMS | ENGINEERING, BIOMEDICAL | ALGORITHM | TACHYCARDIA | MORPHOLOGY DISCRIMINATION | ICDS | Heart Failure - prevention & control | Heart Failure - complications | Electric Injuries - diagnosis | Defibrillators, Implantable - adverse effects | Electric Injuries - prevention & control | Humans | Adult | Male | Electric Injuries - etiology | Heart Failure - diagnosis | Motor Activity | Equipment Failure | Physical fitness | Exercise | Defibrillators | Implants, Artificial | Prosthesis
Journal Article
Journal of Cardiovascular Electrophysiology, ISSN 1045-3873, 03/2007, Volume 18, Issue 3, pp. 326 - 328
Introduction: Inappropriate implantable cardioverter defibrillator (ICD) therapy carries a low but relevant risk of ventricular proarrhythmia. In the present...
implantable cardioverter defibrillator | inappropriate ICD therapy | proarrhythmia | proarrhythmic ICD shock | Proarrhythmic ICD shock | Proarrhythmia | Inappropriate ICD therapy | Implantable cardioverter defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | PATIENT ALERT | LEAD FAILURE | ALGORITHM | DUAL-CHAMBER | IMPLANTABLE-CARDIOVERTER-DEFIBRILLATOR | Prosthesis Failure | Defibrillators, Implantable - adverse effects | Humans | Middle Aged | Fatal Outcome | Male | Hypoxia, Brain - etiology | Ventricular Fibrillation - therapy | Ventricular Fibrillation - etiology | Arrhythmia
implantable cardioverter defibrillator | inappropriate ICD therapy | proarrhythmia | proarrhythmic ICD shock | Proarrhythmic ICD shock | Proarrhythmia | Inappropriate ICD therapy | Implantable cardioverter defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | PATIENT ALERT | LEAD FAILURE | ALGORITHM | DUAL-CHAMBER | IMPLANTABLE-CARDIOVERTER-DEFIBRILLATOR | Prosthesis Failure | Defibrillators, Implantable - adverse effects | Humans | Middle Aged | Fatal Outcome | Male | Hypoxia, Brain - etiology | Ventricular Fibrillation - therapy | Ventricular Fibrillation - etiology | Arrhythmia
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, p. 21748
The programming of implantable cardioverter-defibrillators (ICDs) influences inappropriate shock rates. The aim of the study is to analyse rates of patients...
IMPACT | IMPLANTABLE DEFIBRILLATORS | THERAPY | ICD | PRIMARY PREVENTION PATIENTS | MULTIDISCIPLINARY SCIENCES | Tachycardia, Ventricular - therapy | Heart Rate | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Death, Sudden, Cardiac | Algorithms | Electric Countershock - instrumentation | Defibrillators, Implantable | Female | Aged | Software | Electric Countershock - methods | Tachycardia | Fibrillation | Ventricle | Defibrillators | Cardiovascular diseases | Life Sciences
IMPACT | IMPLANTABLE DEFIBRILLATORS | THERAPY | ICD | PRIMARY PREVENTION PATIENTS | MULTIDISCIPLINARY SCIENCES | Tachycardia, Ventricular - therapy | Heart Rate | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Death, Sudden, Cardiac | Algorithms | Electric Countershock - instrumentation | Defibrillators, Implantable | Female | Aged | Software | Electric Countershock - methods | Tachycardia | Fibrillation | Ventricle | Defibrillators | Cardiovascular diseases | Life Sciences
Journal Article
Chest, ISSN 0012-3692, 08/2018, Volume 154, Issue 2, pp. 302 - 308
Sepsis remains a significant cause of morbidity and mortality in the United States, leading to the implementation of the Severe Sepsis and Septic Shock Early...
lactic acid | critical care | septic shock | sepsis | UNITED-STATES | MORTALITY | INTERNATIONAL CONSENSUS DEFINITIONS | GUIDELINES | IMPLEMENTATION | ORGAN FAILURE | SERUM LACTATE | RESPIRATORY SYSTEM | INFECTION | EPIDEMIOLOGY | CRITICAL CARE MEDICINE | Care and treatment | Physicians | United States | Patient outcomes | Analysis | Practice | Medical care | Sepsis | Management | Patients | CMS, Centers for Medicare & Medicaid Services | ICD, International Statistical Classification of Diseases | SIRS, systemic inflammatory response syndrome | SEP-1, Severe Sepsis and Septic Shock Early Management Bundle | eCART, Electronic Cardiac Arrest Risk Triage | Critical Care | IQR, interquartile ratio | IVF, intravenous fluids
lactic acid | critical care | septic shock | sepsis | UNITED-STATES | MORTALITY | INTERNATIONAL CONSENSUS DEFINITIONS | GUIDELINES | IMPLEMENTATION | ORGAN FAILURE | SERUM LACTATE | RESPIRATORY SYSTEM | INFECTION | EPIDEMIOLOGY | CRITICAL CARE MEDICINE | Care and treatment | Physicians | United States | Patient outcomes | Analysis | Practice | Medical care | Sepsis | Management | Patients | CMS, Centers for Medicare & Medicaid Services | ICD, International Statistical Classification of Diseases | SIRS, systemic inflammatory response syndrome | SEP-1, Severe Sepsis and Septic Shock Early Management Bundle | eCART, Electronic Cardiac Arrest Risk Triage | Critical Care | IQR, interquartile ratio | IVF, intravenous fluids
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 06/2016, Volume 39, Issue 6, pp. 557 - 564
Background Sympathetic activation in heart failure patients favors the development of ventricular arrhythmias, thus leading to an increased risk of sudden...
defibrillation‐ICD | congestive heart failure | Defibrillation-ICD | Congestive heart failure | defibrillation-ICD | Heart Failure - therapy | Receptors, Adrenergic, beta-2 - genetics | Defibrillators, Implantable | Humans | Middle Aged | Risk Factors | Heart Failure - physiopathology | Female | Heart Failure - genetics | Male | Receptors, Adrenergic, beta-1 - genetics | Polymorphism, Genetic | Heart failure | Prevention | Heart | Defibrillators | Implants, Artificial | Prosthesis | Genetic aspects | Glycine
defibrillation‐ICD | congestive heart failure | Defibrillation-ICD | Congestive heart failure | defibrillation-ICD | Heart Failure - therapy | Receptors, Adrenergic, beta-2 - genetics | Defibrillators, Implantable | Humans | Middle Aged | Risk Factors | Heart Failure - physiopathology | Female | Heart Failure - genetics | Male | Receptors, Adrenergic, beta-1 - genetics | Polymorphism, Genetic | Heart failure | Prevention | Heart | Defibrillators | Implants, Artificial | Prosthesis | Genetic aspects | Glycine
Journal Article
EUROPACE, ISSN 1099-5129, 06/2016, Volume 18, Issue 6, pp. 828 - 835
Although most implantable cardioverter-defibrillator (ICD) patients cope well, fears about receiving ICD shocks have been identified as a major determinant of...
CARDIAC & CARDIOVASCULAR SYSTEMS | DEPRESSION SCALE | MANAGEMENT | ICD-related concerns | HOSPITAL ANXIETY | SYMPTOMS | RECIPIENTS | Implantable cardioverter-defibrillator | TRIAL | Mediators | Psychological distress | ICD shocks | QUALITY-OF-LIFE | STRESS | GENDER-DIFFERENCES | ASSOCIATION | Electric Countershock - psychology | Cross-Sectional Studies | Humans | Middle Aged | Self Report | Cardiovascular Diseases - therapy | Depression | Logistic Models | Male | Defibrillators, Implantable - psychology | Young Adult | Psychiatric Status Rating Scales | Sweden | Aged, 80 and over | Quality of Life | Stress, Psychological | Adult | Female | Aged | Anxiety | Adaptation, Psychological | Databases, Factual | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Implantable cardioverter-defibrillator; ICD-related concerns; ICD shocks; Mediators; Psychological distress | Klinisk medicin
CARDIAC & CARDIOVASCULAR SYSTEMS | DEPRESSION SCALE | MANAGEMENT | ICD-related concerns | HOSPITAL ANXIETY | SYMPTOMS | RECIPIENTS | Implantable cardioverter-defibrillator | TRIAL | Mediators | Psychological distress | ICD shocks | QUALITY-OF-LIFE | STRESS | GENDER-DIFFERENCES | ASSOCIATION | Electric Countershock - psychology | Cross-Sectional Studies | Humans | Middle Aged | Self Report | Cardiovascular Diseases - therapy | Depression | Logistic Models | Male | Defibrillators, Implantable - psychology | Young Adult | Psychiatric Status Rating Scales | Sweden | Aged, 80 and over | Quality of Life | Stress, Psychological | Adult | Female | Aged | Anxiety | Adaptation, Psychological | Databases, Factual | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Implantable cardioverter-defibrillator; ICD-related concerns; ICD shocks; Mediators; Psychological distress | Klinisk medicin
Journal Article
Europace, ISSN 1099-5129, 2016, Volume 18, Issue 6, pp. 828 - 835
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 18, pp. 1674 - 1679
Objectives This study sought to determine if the risk of mortality associated with inappropriate implantable cardioverter-defibrillator (ICD) shocks is due to...
Cardiovascular | Internal Medicine | atrial fibrillation | ventricular tachycardia | cardiac resynchronization therapy | implantable cardioverter defibrillators | MYOCARDIAL DAMAGE | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | ALTITUDE | ICD | ATRIAL-FIBRILLATION | IMPACT | REDUCTION | OUTCOMES | CONGESTIVE-HEART-FAILURE | Sects | Defibrillators | Implants, Artificial | Prosthesis | Mortality | Studies | Cardiac arrhythmia | Sinuses | Noise | Medical prognosis | Monitoring systems | Statistical methods | Age
Cardiovascular | Internal Medicine | atrial fibrillation | ventricular tachycardia | cardiac resynchronization therapy | implantable cardioverter defibrillators | MYOCARDIAL DAMAGE | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | ALTITUDE | ICD | ATRIAL-FIBRILLATION | IMPACT | REDUCTION | OUTCOMES | CONGESTIVE-HEART-FAILURE | Sects | Defibrillators | Implants, Artificial | Prosthesis | Mortality | Studies | Cardiac arrhythmia | Sinuses | Noise | Medical prognosis | Monitoring systems | Statistical methods | Age
Journal Article
Heart Rhythm, ISSN 1547-5271, 11/2019, Volume 16, Issue 11, pp. 1729 - 1737
Implantable cardioverter-defibrillators (ICDs) use low-voltage measures of shock impedance (LVSZ) to monitor integrity of leads. To determine the separation...
Insulation | Leads | Defibrillation | Impedance | Implantable cardioverter-defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | ICD LEAD | ALGORITHM | FRACTURES | DELIVERY | PULSES | Shock | Electrolytes | Defibrillators | Electric countershock | Implants, Artificial | Prosthesis
Insulation | Leads | Defibrillation | Impedance | Implantable cardioverter-defibrillator | CARDIAC & CARDIOVASCULAR SYSTEMS | ICD LEAD | ALGORITHM | FRACTURES | DELIVERY | PULSES | Shock | Electrolytes | Defibrillators | Electric countershock | Implants, Artificial | Prosthesis
Journal Article
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 11/2019, Volume 42, Issue 11, pp. 1496 - 1498
Coronary disease is a common condition in patients affected by heart failure with severely reduced ejection fraction (HFrEF). This condition represents an...
percutaneous coronary intervention | inappropriate shock | ICD implantation | Transluminal angioplasty | Arrhythmia | Implants, Artificial | Prosthesis | Cardiac patients | Defibrillators | Heart diseases | Quality of life
percutaneous coronary intervention | inappropriate shock | ICD implantation | Transluminal angioplasty | Arrhythmia | Implants, Artificial | Prosthesis | Cardiac patients | Defibrillators | Heart diseases | Quality of life
Journal Article
Journal of Electrocardiology, ISSN 0022-0736, 2019, Volume 56, pp. 1 - 3
AbstractWe present a case of combination of a leadless pacemaker (Micra) and a subcutaneous implantable cardioverter-defibrillator (S-ICD). The patient had a...
Cardiovascular | Effective shock treatment | Subcutaneous defibrillator (S-ICD) | Leadless pacemaker | Ventricular fibrillation (VF) | LEADS | CARDIAC & CARDIOVASCULAR SYSTEMS | Shock | Defibrillators | Arrhythmia | Implants, Artificial | Prosthesis | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinteknik | Medical Equipment Engineering | Klinisk medicin | Teknik | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medicinsk apparatteknik | Engineering and Technology | Medical Engineering
Cardiovascular | Effective shock treatment | Subcutaneous defibrillator (S-ICD) | Leadless pacemaker | Ventricular fibrillation (VF) | LEADS | CARDIAC & CARDIOVASCULAR SYSTEMS | Shock | Defibrillators | Arrhythmia | Implants, Artificial | Prosthesis | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinteknik | Medical Equipment Engineering | Klinisk medicin | Teknik | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medicinsk apparatteknik | Engineering and Technology | Medical Engineering
Journal Article
Europace, ISSN 1099-5129, 10/2003, Volume 5, Issue 4, pp. 381 - 389
Aims. The experiences of patients who received shocks from their implantable cardioverter defibrillator (ICD) and how these events affect their overall...
Defibrillation shocks | ICDs | Quality of life | TRIAL | DEPRESSION | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | defibrillation shocks | ANXIETY | ACCEPTANCE | quality of life | VENTRICULAR ARRHYTHMIAS | CARE | Depression - epidemiology | Prospective Studies | Arrhythmias, Cardiac - therapy | Humans | Middle Aged | Male | Defibrillators, Implantable - psychology | Case-Control Studies | Socioeconomic Factors | Activities of Daily Living | Anxiety - epidemiology | Quality of Life | Female | Arrhythmias, Cardiac - psychology | Longitudinal Studies | Adaptation, Psychological
Defibrillation shocks | ICDs | Quality of life | TRIAL | DEPRESSION | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | defibrillation shocks | ANXIETY | ACCEPTANCE | quality of life | VENTRICULAR ARRHYTHMIAS | CARE | Depression - epidemiology | Prospective Studies | Arrhythmias, Cardiac - therapy | Humans | Middle Aged | Male | Defibrillators, Implantable - psychology | Case-Control Studies | Socioeconomic Factors | Activities of Daily Living | Anxiety - epidemiology | Quality of Life | Female | Arrhythmias, Cardiac - psychology | Longitudinal Studies | Adaptation, Psychological
Journal Article